<DOC>
	<DOCNO>NCT02850276</DOCNO>
	<brief_summary>The purpose study explore possible link autonomic nervous system immune function patient HIV . Sometimes HIV cause nerve function abnormally , call HIV-associated autonomic neuropathy ( HIV-AN ) . HIV-AN condition different person person . In people cause symptom harmful , others may cause symptom dizziness lightheadedness , nausea , vomit , diarrhea , constipation , problem urinate . Most people HIV-AN n't know . One important nerve autonomic nervous system vagus nerve . Abnormal function vagus nerve may cause stomach intestinal slowing , could lead overgrowth bacteria . The body sense bacteria try fight , lead inflammation . In study researcher test whether abnormal function vagus nerve HIV associate stomach slow overgrowth bacteria , drug call pyridostigmine help .</brief_summary>
	<brief_title>Autonomic Neuropathy , GI Motility , Inflammation HIV</brief_title>
	<detailed_description>HIV-infected patient commonly develop autonomic neuropathy ( HIV-AN ) , heterogeneous disorder characterize vary degree sympathetic vagal dysfunction . We hypothesize vagal component HIV-AN contribute chronic inflammation , directly via loss cholinergic activity , indirectly via effect GI tract , effect treatable use acetylcholinesterase inhibitor pyridostigmine . The autonomic nervous system control inflammatory response lipopolysaccharide ( LPS ) via cholinergic anti-inflammatory pathway . This pathway mediate vagus nerve , therefore likely impaired HIV-AN vagal dysfunction . Vagal dysfunction also cause slow GI transit , could exacerbate LPS-driven inflammation promote bacterial overgrowth . However , anti-inflammatory impact cholinergic pathways almost completely unstudied HIV , despite know importance inflammation HIV disease progression . Therefore , exploratory pilot , seek establish association vagal dysfunction , GI motility inflammation virally suppress , CART-treated individual HIV-AN . Specific Aim 1 : To determine whether vagal dysfunction associate immune activation CART-treated participant HIV-AN , estimate extent association mediate GI effect ( i.e . slow motility , bacterial overgrowth , microbial translocation ) versus direct effect vagal dysfunction . Specific Aim 2 : In subset participant vagal GI dysfunction , investigate whether 8 week pyridostigmine : ) reduce immune activation , b ) improve GI motility ; immune effect depend GI effect . To achieve aim , participant HIV-AN GI symptom assess : vagal dysfunction ( heart rate variability ) ; GI dysmotility ( gastric empty scintigraphy ) ; small intestinal bacterial overgrowth ( breath test ) ; microbial translocation ( LPS sCD14 ) ; immune activation ( IL-6 CRP ) . Participants meet threshold criterion vagal GI dysfunction treat pyridostigmine 8 week , GI immune measure reassess . Objectives Specific Aim 1 : To determine whether vagal dysfunction associate immune activation HIV-infected participant treat combination antiretroviral therapy ( CART ) , estimate extent association mediate GI effect ( i.e . slow motility , bacterial overgrowth , microbial translocation ) versus direct effect vagal dysfunction . Specific Aim 2 : In subset participant vagal GI dysfunction , investigate whether 8 week pyridostigmine : ) reduce immune activation , b ) improve GI motility ; effect present determine whether immune effect depend GI effect .</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Pyridostigmine Bromide</mesh_term>
	<criteria>≥18 year old Documented evidence HIV1 infection Stable CART therapy ≥3 month Most recent HIV1 viral load ≤100 copies/ml ( value must within past six month ) English speak Able tolerate autonomic testing ( e.g . able stand , able perform Valsalva maneuver ) . If use nicotinecontaining product willing refrain use 24 hour prior test procedure ( autonomic reflex screen , breath testing , gastric empty ) ≥1 GI symptom Survey Autonomic Symptoms ( SAS ) 47 Diagnosis know cause autonomic dysfunction HIV ( e.g . Parkinson 's disease , diabetes ) Diagnosis know cause GI dysfunction HIV ( e.g . peptic ulcer disease , infectious diarrhea ) Current use follow class medication ( due potential significant autonomic GI effect , interaction pyridostigmine , interference one testing procedure ) Prokinetics ( e.g . metoclopramide ) Antidiarrheals ( e.g . loperamide ) Antibiotics Mefloquine Medical psychiatric condition preclude safe participation study procedure deem likely result hospitalization study period . The presence one follow diagnosis render Valsalva maneuver relatively absolutely contraindicate : uncontrolled glaucoma , aortic stenosis , myocardial infarction last 6 month , retinopathy unclipped cerebral aneurysm . The presence one follow diagnosis impede interpretation autonomic testing : cardiac arrhythmia pacemaker . An allergy egg ( contraindication gastric empty scintigraphy ) Any follow laboratory result : Positive pregnancy test ( administer woman childbearing potential ) Urine toxicology screen positive stimulant ( e.g . amphetamine , cocaine ) opiates/opioids .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>HIV disease</keyword>
	<keyword>gastrointestinal problem</keyword>
</DOC>